In Silico Characterization of the Human Parkin Protein and Hypothetical Crispr/Cas9 Gene Editing Design for Modeling Parkinsonism
Abstract
PRKN-associated parkinsonism represents one of the most prominent genetic causes of early-onset autosomal recessive parkinsonism. This study reports an exploratory in silico characterization of the human PRKN gene and a theoretical CRISPR/Cas9 gene editing design for exon disruption. Using genomic and protein databases (NCBI, Ensembl, STRING) along with predictive sequence algorithms (TMHMM, Clustal Omega), the genomic architecture of PRKN (transcript NM_004562.3) was mapped and evaluated sequence conservation and topological properties of the Parkin protein (NP_004553.2). TMHMM analysis confirmed the absence of hydrophobic transmembrane helices, consistent with Parkin’s established role as a cytosolic protein with a posterior probability of 1.0 across all 465 amino acids. Multiple sequence alignments demonstrated high conservation of key functional domains across evolutionary distinct species (Homo sapiens, Pan troglodytes, Mus musculus, Danio rerio, and Drosophila melanogaster). Using CRISPR Finder and SnapGene, a highly specific SpCas9 gRNA (5’-GCTTAGACTGTTTCCACTTA-3’) targeting Exon 2 to model gene disruption was designed with an on-target efficiency score of 78. Peak predicted off-target sites were mapped on Chromosomes 1 and 12, each bearing three mismatches located outside functional exons. A conceptual PCR assay was simulated to illustrate hypothetical frameshift indel outcomes. This study provides a purely computational framework to guide future in vitro modeling of PRKN loss-of-function in cell-line models.